Literature DB >> 8495762

Clomiphene citrate affects cervical mucus and endometrial morphology independently of the changes in plasma hormonal levels induced by multiple follicular recruitment.

M R Massai1, D de Ziegler, V Lesobre, C Bergeron, R Frydman, P Bouchard.   

Abstract

OBJECTIVE: To analyze the effects of clomiphene citrate (CC) on cervical mucus (CM) and endometrial morphology independently of hormonal changes encountered when CC is administered for ovulation induction.
DESIGN: Volunteers whose ovarian functions were temporarily suppressed (n = 18) by a long-acting GnRH agonist and 6 women of similar age suffering from premature ovarian failure (POF) received E2 and P. Half of the women also received CC (50 mg/d, days 2 to 6).
SETTING: Tertiary University Institution, Hôpital A. Béclère. PATIENTS, PARTICIPANTS: Eighteen volunteers suffering from infertility not related to a uterine cause and 6 women of similar age suffering from POF. MAIN OUTCOME MEASURE: Plasma gonadotropins, E2, and P were measured at baseline to confirm that the ovaries were inactive and twice weekly during physiological E2 and P replacement. Cervical mucus was analyzed on day 14 and scored from 0 to 15. Endometrial biopsies were obtained on replacement days 20 and 24 for conventional histology and immunocytochemistry analysis of estrogen receptors and progesterone receptors (PR). Premature ovarian failure women whose results have been previously published served as controls for day 20 biopsies.
RESULTS: Cervical mucus scored lower in women who received CC (5.5 +/- 3.2) than in controls (13.6 +/- 4.7, mean +/- SEM). On day 20, endometrial findings were similar in women treated with CC and in controls. On day 24, specimens showed a significant delay in endometrial maturation in women treated with CC. On day 24, only staining for PR selectively persisted in endometrial stroma, and no difference was observed between women who received CC and controls.
CONCLUSION: Our results indicate that CC significantly alters CM quality and late luteal phase endometrial morphology despite physiological levels of plasma E2 and P. Hence, clinicians should monitor E2 levels when using CC, and caution should be exerted when supraphysiological levels of E2 are not present to counterbalance the effects of CC on the CM and the endometrium.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8495762     DOI: 10.1016/s0015-0282(16)55973-1

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  Defining the proliferative phase endometrial defect.

Authors:  Jason G Bromer; Tamir S Aldad; Hugh S Taylor
Journal:  Fertil Steril       Date:  2008-03-07       Impact factor: 7.329

Review 2.  The Potential Relationship Between Different Human Female Reproductive Disorders and Sperm Quality in Female Genital Tract.

Authors:  Forough Mahdavinezhad; Roghaye Gharaei; Ahmad Reza Farmani; Farideh Hashemi; Mahsa Kouhestani; Fardin Amidi
Journal:  Reprod Sci       Date:  2021-04-14       Impact factor: 3.060

3.  Extended letrozole regimen versus clomiphene citrate for superovulation in patients with unexplained infertility undergoing intrauterine insemination: a randomized controlled trial.

Authors:  Usama M Fouda; Ahmed M Sayed
Journal:  Reprod Biol Endocrinol       Date:  2011-06-21       Impact factor: 5.211

4.  Effect of clomiphene citrate on uterine hemodynamics in women with unexplained infertility.

Authors:  Eman Omran; Mohamed El-Sharkawy; Akmal El-Mazny; Mohamed Hammam; Wafaa Ramadan; Dina Latif; Dalia Samir; Sherine Sobh
Journal:  Int J Womens Health       Date:  2018-04-04

5.  Effects of clomiphene citrate plus estradiol or progesterone on endometrial ultrastructure: An RCT.

Authors:  Robabeh Taheripanah; Maryam Kabir-Salmani; Masoomeh Favayedi; Marzieh Zamaniyan; Narges Malih; Anahita Taheripanah
Journal:  Int J Reprod Biomed       Date:  2020-03-29

6.  Endometrial thickness as a biomarker for ongoing pregnancy in IUI for unexplained subfertility: a secondary analysis.

Authors:  N A Danhof; R van Eekelen; S Repping; B W J Mol; F van der Veen; M van Wely; M H Mochtar
Journal:  Hum Reprod Open       Date:  2020-01-08

7.  Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome.

Authors:  S A Amer; J Smith; A Mahran; P Fox; A Fakis
Journal:  Hum Reprod       Date:  2017-08-01       Impact factor: 6.918

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.